LabPulse.com
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
  • Sign In
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Stay in the Know
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
I have read and agree to the privacy policy & terms of service and wish to opt-in.
Business Insights
  • Policy & Regulation
  • Trends & Finance
Research & Development
  • Clinical Trials
  • Collaboration
  • Funding
Diagnostic Technologies
  • Clinical Chemistry
  • Emerging Technology
  • Immunoassays
  • Molecular Diagnostics
  • Pathology & AI
Diseases
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
User Tools
  • Sign In
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon
  • Business Insights
    • Policy & Regulation
    • Trends & Finance
  • Diagnostic Technologies
    • Clinical Chemistry
    • Emerging Technology
    • Immunoassays
    • Molecular Diagnostics
    • Pathology & AI
  • Diseases
    • Autoimmune
    • Cancer
    • Cardiovascular
    • COVID-19
    • Health Topics
    • Infectious
  • Point-of-Care Testing
  • Research & Development
    • Clinical Trials
    • Collaboration
    • Funding
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
  • Sign In
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon

Site Map

  1. 2023
  2. January
  3. 18
With Bill & Melinda Gates Foundation grant, VisualDx to develop diagnostic, surveillance tools for underserved
Targeted clinician intervention might improve follow-up colonoscopy rates: Exact Sciences funded study
Axim Biotechnologies developing point-of-care assay to measure fentanyl neutralizing antibodies
Netherlands Cancer Institute transitioning to Proscia digital pathology platform
Qiagen launches molecular diagnostic platform for automated sample processing
Newborn screening for neuromuscular disorder leads to improved outcomes in Australian study
Page 1 of 1
LabPulse.com
Topics
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon
  1. Privacy Policy
  2. Contact Us
  3. Site Map
© 2023 Science and Medicine Group. All rights reserved.